Rapid Identification and Antimicrobial Susceptibility Testing of Positive Blood Cultures Using MALDI-TOF MS and a Modification of the Standardised Disc Diffusion Test: a Pilot Study
Overview
Affiliations
Aims: In an era when clinical microbiology laboratories are under increasing financial pressure, there is a need for inexpensive, yet effective, rapid microbiology tests. The aim of this study was to evaluate a novel modification of standard methodology for the identification and antimicrobial susceptibility testing (AST) of pathogens in positive blood cultures, reducing the turnaround time of laboratory results by 24 h.
Methods: 277 positive blood cultures had a Gram stain performed and were subcultured and incubated at 37°C in a CO atmosphere for 4-6 h. Identification of the visible growth was performed using matrix-assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS). Taking a modified approach to the Clinical and Laboratory Standards Institute-standardised AST methodology, an inoculum density of 0.5 McFarland was prepared from the early growth for disc diffusion testing. The standard AST method was also performed on the 18-24 h culture.
Results: 96% (n=73/76) of gram-negative organisms were correctly identified by MALDI-TOF MS. Comparative analysis of the rapid and standard AST results showed an overall interpretive category error rate of 7.7% (6.7% minor errors, 0.6% major errors and 0.4% very major errors). 100% of Staphylococcus aureus (n=41) and enterococcus isolates (n=9) were correctly identified after 4-6 h incubation. The overall AST categorical agreement was also 100% for these isolates.
Conclusions: An incubation of 4-6 h directly from positive blood cultures allowed for both a rapid species identification and an antimicrobial susceptibility result approximately 24 h earlier than is possible using standard methodology.
Cintron M, Clark B, Miranda E, Babady N J Clin Microbiol. 2024; 63(2):e0132024.
PMID: 39704521 PMC: 11837544. DOI: 10.1128/jcm.01320-24.
Buonomini A, Riva E, Di Bonaventura G, Gherardi G Diagnostics (Basel). 2020; 10(10).
PMID: 33076535 PMC: 7602724. DOI: 10.3390/diagnostics10100830.
Akerlund A, Jonasson E, Matuschek E, Serrander L, Sundqvist M, Kahlmeter G J Antimicrob Chemother. 2020; 75(11):3230-3238.
PMID: 32789506 PMC: 7566356. DOI: 10.1093/jac/dkaa333.
Van den Poel B, Meersseman P, Debaveye Y, Klak A, Verhaegen J, Desmet S Eur J Clin Microbiol Infect Dis. 2019; 39(1):53-63.
PMID: 31624985 DOI: 10.1007/s10096-019-03690-0.
Van den Poel B, Klak A, Desmet S, Verhaegen J Eur J Clin Microbiol Infect Dis. 2018; 37(9):1753-1760.
PMID: 29961166 DOI: 10.1007/s10096-018-3309-4.